Thermo Scientific™ Sensititre™ EUMDR2F

Confidently perform antimicrobial susceptibility testing (AST) of clinically relevant non-fastidious Gram-negative isolates on a single comprehensive AST panel now containing Aztreonam / Avibactam, Cefepime / Emnetazobactam, and Sulbactam / Durlobactam. Generate clinically impactful data, detect emerging resistance, and help guide timely and accurate antimicrobial therapy by utilising micro-broth dilution - the gold standard¹ phenotypic method for AST.

This convenient panel meets EUCAST breakpoints for a broad range of relevant second line antimicrobials, including Ceftazidime / Avibactam, Colistin, Eravacycline, Imipenem / Relebactam, and Meropenem / Vaborbactam.

Key features and product benefits:

• Deliver consistent turnaround times to support earlier clinical decision-making and targeted therapy, particularly in critical infections such as sepsis.
• Monitor susceptibility among critical Gram-negative isolates with full-range, accurate MIC values for a broad array of clinically relevant antimicrobics.
• For ultimate flexibility automated or manual read options are available with one panel; compatible with all Sensititre™ instrumentation options - designed to be modular in order to meet the unique needs of individual lab space, workload, and budget requirements.
• Eliminate inventory control concerns with extended shelf life (24-months), and room temperature storage.
• Individual packaging allows testing of one sample at a time, with reduced waste.

Not all products are available for sale in all territories. Please inquire.

For In Vitro Diagnostic Use.

1. Jayol A, Nordmann P, Andre C, Poirel L, Dubois V. Evaluation of three broth microdilution systems to determine colistin susceptibility of Gram-negative bacilli. J Antimicrob Chemother. 2018; 73: 1272-1278. PubMed